T1	p 66 97	adults with autistic disorder .
T2	p 379 400	persons with autism .
T3	p 508 554	Thirty adults with autistic disorder completed
T4	p 1703 1741	children and adolescents with autism .
T5	i 23 41	placebo-controlled
T6	i 51 62	fluvoxamine
T7	i 580 598	placebo-controlled
T8	i 660 681	fluvoxamine maleate .
T9	i 907 914	placebo
T10	i 936 947	Fluvoxamine
T11	i 964 971	placebo
T12	i 1355 1366	fluvoxamine
T13	i 1472 1483	Fluvoxamine
T14	i 1507 1514	placebo
T15	i 1614 1625	fluvoxamine
T16	o 682 700	Behavioral ratings
T17	o 984 1016	repetitive thoughts and behavior
T18	o 1032 1052	maladaptive behavior
T19	o 1072 1082	aggression
T20	o 1119 1148	aspects of social relatedness
T21	o 1174 1182	language
T22	o 1315 1334	sedation and nausea
T23	o 1376 1448	tolerated . No dyskinesias , adverse cardiovascular events , or seizures